Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients (AZTlowdose)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by University Hospital, Geneva.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Rougemont Mathieu, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01540240
First received: February 22, 2012
Last updated: February 27, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)